Clinical trial
Danish Multicenter Study of Adalimumab in Spondyloarthritis
NCT00477893 · Glostrup University Hospital, Copenhagen, Other · Unknown status
Key facts
| NCT number | NCT00477893 |
|---|---|
| Title | Danish Multicenter Study of Adalimumab in Spondyloarthritis |
| Official title | Can New Imaging- and Bio-markers Improve the Assessment of Disease Activity and Progression and Predict Therapeutic Outcome in Spondyloarthritis Patients Receiving Adalimumab |
| Acronym | DANISH |
| Lead sponsor | Glostrup University Hospital, Copenhagen, Other |
| Collaborators | Abbott Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Spondyloarthritis |
| Intervention type | Drug |
| Interventions | Adalimumab, Placebo |
| Enrollment | 52 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2013 |
| First posted | May 24, 2007 |
| Last update posted | Mar 28, 2012 |
| Countries | Denmark |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: